LGND – Ligand Pharmaceuticals
Investors holding1
Combined shares9,763
Combined reported value$3.0M
LGND chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Ray Dalio narrow view | 0.01 | New | 9,763 | $3.0M | Q3 2026 |
Activity: last 4 quarters
Added: opened or increased
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q1 2026 | Ray Dalio narrow view | Closed | 0 | 0.00 |
History
1 peakQ3 2026: 1 tracked investors
20132026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Ray Dalio | 9.8K | – | – | 4.2K | 1.3K | – | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).